Filing Details
- Accession Number:
- 0001179110-20-009257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-24 17:45:44
- Reporting Period:
- 2020-08-19
- Accepted Time:
- 2020-08-24 17:45:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1286370 | R Michael Minogue | C/O Abiomed, Inc., 22 Cherry Hill Drive Danvers MA 01923 | Chairman, President, Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Disposition | 2020-08-19 | 20,883 | $0.00 | 210,746 | No | 4 | G | Direct | |
| Common Stock $.01 Par Value | Acquisiton | 2020-08-20 | 60,000 | $22.44 | 270,746 | No | 4 | M | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-20 | 3,759 | $309.40 | 266,987 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-20 | 27,480 | $310.09 | 239,507 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-20 | 14,196 | $311.09 | 225,311 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-20 | 5,596 | $312.08 | 219,715 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-20 | 6,254 | $313.23 | 213,461 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-20 | 2,715 | $314.13 | 210,746 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Acquisiton | 2020-08-21 | 40,000 | $22.44 | 250,746 | No | 4 | M | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-21 | 14,600 | $305.20 | 236,146 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-21 | 9,235 | $306.11 | 226,911 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-21 | 11,189 | $307.24 | 215,722 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-21 | 4,876 | $307.96 | 210,846 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Disposition | 2020-08-21 | 100 | $310.10 | 210,746 | No | 4 | S | Direct | |
| Common Stock $.01 Par Value | Acquisiton | 2020-08-19 | 20,883 | $0.00 | 52,555 | No | 4 | G | Indirect | By Trust - A |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | G | Indirect | By Trust - A |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-08-20 | 100,000 | $0.00 | 100,000 | $22.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-05-22 | 2022-05-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock $.01 Par Value | 73,745 | Indirect | By Trust - B |
| Common Stock $.01 Par Value | 32,810 | Indirect | By Trust - C |
| Common Stock $.01 Par Value | 655 | Indirect | By Trust - D |
| Common Stock $.01 Par Value | 38,560 | Indirect | By Trust - E |
| Common Stock $.01 Par Value | 85,040 | Indirect | By Trust - F |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 85,000 | Direct |
| Common Stock | Stock Option (right to buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 85,000 | Direct |
| Common Stock | Stock Option (right to buy) | $66.25 | 2016-05-13 | 2025-05-13 | 0 | 35,000 | Direct |
| Common Stock | Stock Option (right to buy) | $99.62 | 2017-05-24 | 2026-05-24 | 0 | 30,500 | Direct |
| Common Stock | Stock Option (right to buy) | $134.51 | 2018-05-15 | 2027-05-15 | 0 | 33,000 | Direct |
| Common Stock | Stock Option (right to buy) | $381.97 | 2019-05-16 | 2028-05-16 | 0 | 30,000 | Direct |
| Common Stock | Stock Option (right to buy) | $266.39 | 2020-05-30 | 2029-05-30 | 0 | 50,000 | Direct |
| Common Stock | Stock Option (Right to Buy) | $223.90 | 2021-05-29 | 2030-05-29 | 0 | 20,898 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2023-05-14 | 0 | 85,000 | Direct |
| 2024-05-14 | 0 | 85,000 | Direct |
| 2025-05-13 | 0 | 35,000 | Direct |
| 2026-05-24 | 0 | 30,500 | Direct |
| 2027-05-15 | 0 | 33,000 | Direct |
| 2028-05-16 | 0 | 30,000 | Direct |
| 2029-05-30 | 0 | 50,000 | Direct |
| 2030-05-29 | 0 | 20,898 | Direct |
Footnotes
- These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- Exercise of stock options pursuant to reporting owners 10b5-1 plan.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $304.6400 and $314.8000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse is a trustee of the trust.
Billionaire Hedge Funds
